Discover 792 paid clinical trials in Round Rock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 792
Featured
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
for
Crohn's Disease, Ulcerative Colitis
Location: Georgetown TX, San Antonio TX, Shenandoah TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07697456
Phase 2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Austin TX, Richardson TX, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07145918
Phase 2, Recruiting
Featured
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Austin TX, San Antonio TX, The Woodlands TX, Houston TX,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
Featured
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
for
HER2-positive Breast Cancer
Location: Austin TX, Fort Worth TX, Germantown TN, Huntsville AL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07413939
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Austin TX, Houston TX, Fort Worth TX, Grapevine TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase 2, Recruiting
Featured
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Austin TX, Waxahachie TX, Houston TX, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Featured
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Austin TX, Webster TX, Kansas City MO, Omaha NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06820463
Phase 2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Austin TX, Houston TX, Palestine TX, Lincoln NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase 2, Phase 3, Recruiting
Featured
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Round Rock TX, San Marcos TX, Schertz TX,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07496567
Phase 2, Phase 3, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Round Rock TX, Austin TX, San Marcos TX, Tomball TX,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Round Rock TX, Waco TX, San Antonio TX, Dallas TX,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Round Rock TX, Cypress TX, Little Rock AR,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase 2, Recruiting
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Round Rock TX, Shavano Park TX, Houston TX, Mesquite TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
for
Subcutaneous Fat
Location: Pflugerville TX, Baton Rouge LA, Omaha NE, Encinitas CA,
Sponsor: Caliway Biopharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT07140939
Phase 3, Recruiting
Active & Responsive
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
for
Non-segmental Vitiligo
Location: Pflugerville TX, Bellaire TX, Houston TX, Plano TX,